73 related articles for article (PubMed ID: 27161705)
21. Peptides derived from specific interaction sites of the fibroblast growth factor 2-FGF receptor complexes induce receptor activation and signaling.
Manfè V; Kochoyan A; Bock E; Berezin V
J Neurochem; 2010 Jul; 114(1):74-86. PubMed ID: 20374425
[TBL] [Abstract][Full Text] [Related]
22. MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.
Brown KC; Lau JK; Dom AM; Witte TR; Luo H; Crabtree CM; Shah YH; Shiflett BS; Marcelo AJ; Proper NA; Hardman WE; Egleton RD; Chen YC; Mangiarua EI; Dasgupta P
Angiogenesis; 2012 Mar; 15(1):99-114. PubMed ID: 22198237
[TBL] [Abstract][Full Text] [Related]
23. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
24. A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.
Giacomini A; Matarazzo S; Pagano K; Ragona L; Rezzola S; Corsini M; Di Salle E; Presta M; Ronca R
Oncotarget; 2015 May; 6(15):13790-802. PubMed ID: 25912421
[TBL] [Abstract][Full Text] [Related]
25. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
26. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
Giavazzi R; Giuliani R; Coltrini D; Bani MR; Ferri C; Sennino B; Tosatti MP; Stoppacciaro A; Presta M
Cancer Res; 2001 Jan; 61(1):309-17. PubMed ID: 11196179
[TBL] [Abstract][Full Text] [Related]
27. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
[TBL] [Abstract][Full Text] [Related]
28. Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis.
Aviezer D; Cotton S; David M; Segev A; Khaselev N; Galili N; Gross Z; Yayon A
Cancer Res; 2000 Jun; 60(11):2973-80. PubMed ID: 10850445
[TBL] [Abstract][Full Text] [Related]
29. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
30. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
31. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
Simantov R; Febbraio M; Silverstein RL
Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M
FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
[TBL] [Abstract][Full Text] [Related]
33. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
Safran M; Eisenstein M; Aviezer D; Yayon A
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
[TBL] [Abstract][Full Text] [Related]
34. Interaction of clodronate with fibroblast growth factor 2 reduces FGF2-activity in endothelial cells.
Rose K; Finger IE; Ferenz KB
Biomed Pharmacother; 2011 Feb; 65(1):46-51. PubMed ID: 21177067
[TBL] [Abstract][Full Text] [Related]
35. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.
Zubilewicz A; Hecquet C; Jeanny JC; Soubrane G; Courtois Y; Mascarelli F
Oncogene; 2001 Mar; 20(12):1403-13. PubMed ID: 11313884
[TBL] [Abstract][Full Text] [Related]
36. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1.
Shafiee A; Penn JS; Krutzsch HC; Inman JK; Roberts DD; Blake DA
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2378-88. PubMed ID: 10892887
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
[TBL] [Abstract][Full Text] [Related]
39. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor-2 binding to the endothelial basement membrane peaks at a physiologically relevant shear stress.
Reisig K; Clyne AM
Matrix Biol; 2010 Sep; 29(7):586-93. PubMed ID: 20678572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]